L162-0625 Screening compound: 1'-[1-(4-phenylpiperazin-1-yl)isoquinoline-7-carbonyl]-1,4'-bipiperidine

L162-0625 Screening compound: 1'-[1-(4-phenylpiperazin-1-yl)isoquinoline-7-carbonyl]-1,4'-bipiperidine
L162-0625 Screening compound: 1'-[1-(4-phenylpiperazin-1-yl)isoquinoline-7-carbonyl]-1,4'-bipiperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound L162-0625
1'-[1-(4-phenylpiperazin-1-yl)isoquinoline-7-carbonyl]-1,4'-bipiperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L162-0625

Molecular Formula

C30H37N5O (C30 H37 N5 O)

Compound Name

1'-[1-(4-phenylpiperazin-1-yl)isoquinoline-7-carbonyl]-1,4'-bipiperidine

IUPAC name

1'-[1-(4-phenylpiperazin-1-yl)isoquinoline-7-carbonyl]-14'-bipiperidine

SMILES

O=C(c1cc2c(N(CC3)CCN3c3ccccc3)nccc2cc1)N(CC1)CCC1N1CCCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.66

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.609

Distribution Coefficient, logD

1.170

Water Solubility, LogSw

-4.48

Polar Surface Area

35.402

Acid Dissociation Constant (pKa)

23.24

Base Dissociation Constant (pKb)

10.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.70

L162-0625 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L162-0625 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L162-0625?
Check Price and Availability of L162-0625, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L162-0625 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L162-0625
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L162-0625
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L162-0625 available by request